Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD)

Launched by MEDICAL UNIVERSITY INNSBRUCK · Oct 3, 2022

Keywords

ClinConnect Summary

The EVTI-PAD trial is studying how blood flow to the legs is affected in patients with a condition called Peripheral Arterial Disease (PAD), which can cause severe pain and problems with circulation. This study will use common tests to measure blood flow before and after patients undergo standard treatments like surgery or angioplasty, which are procedures to improve blood flow. The goal is to better understand how effective these treatments are for improving circulation in the legs.

To participate in this trial, you need to be between 65 and 74 years old and have symptoms of PAD that require treatment. Unfortunately, if you are under 18, have certain allergies, or have specific kidney issues, you won’t be eligible. If you join the study, you can expect to undergo a few simple tests to check your blood flow, and these will be done both before and after your treatment. This trial is currently looking for participants, and your involvement could help improve future treatments for others with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - patients with symptomatic peripheral arterial disease (Rutherford categories 3-6) requiring revascularization.
• Exclusion Criteria:
• • patients younger than 18 years
• • patients unable to give consent without legal guardians
• • iodine allergy
• • hyperthyroidism
• • allergy to indocyanine green
• • Glomerular filtration rate \<30ml/min/1.73m2